A detailed history of Investors Asset Management Of Georgia Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 7,772 shares of BMY stock, worth $457,537. This represents 0.19% of its overall portfolio holdings.

Number of Shares
7,772
Previous 8,072 3.72%
Holding current value
$457,537
Previous $335,000 20.0%
% of portfolio
0.19%
Previous 0.17%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$39.66 - $51.75 $11,897 - $15,525
-300 Reduced 3.72%
7,772 $402,000
Q2 2024

Jul 29, 2024

BUY
$40.25 - $52.99 $13,121 - $17,274
326 Added 4.21%
8,072 $335,000
Q1 2024

Apr 22, 2024

BUY
$47.98 - $54.4 $69,331 - $78,608
1,445 Added 22.93%
7,746 $420,000
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $8,144 - $9,718
-168 Reduced 2.6%
6,301 $323,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $8,625 - $9,644
-149 Reduced 2.25%
6,469 $375,000
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $9,107 - $10,784
-133 Reduced 1.97%
6,618 $476,000
Q1 2022

Apr 20, 2022

BUY
$61.48 - $73.72 $6,148 - $7,372
100 Added 1.5%
6,751 $493,000
Q3 2021

Oct 14, 2021

SELL
$59.17 - $69.31 $5,917 - $6,931
-100 Reduced 1.48%
6,651 $394,000
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $8,661 - $9,814
-150 Reduced 2.17%
6,751 $419,000
Q3 2020

Oct 14, 2020

BUY
$57.43 - $63.64 $21,536 - $23,865
375 Added 5.75%
6,901 $416,000
Q2 2020

Jul 31, 2020

SELL
$54.82 - $64.09 $5,482 - $6,409
-100 Reduced 1.51%
6,526 $384,000
Q4 2019

Jan 15, 2020

BUY
$49.21 - $64.19 $2,460 - $3,209
50 Added 0.76%
6,626 $425,000
Q3 2019

Oct 17, 2019

BUY
$42.77 - $50.71 $7,912 - $9,381
185 Added 2.89%
6,576 $333,000
Q2 2019

Jul 10, 2019

BUY
$44.62 - $49.34 $26,325 - $29,110
590 Added 10.17%
6,391 $290,000
Q1 2019

Apr 17, 2019

BUY
$45.12 - $53.8 $5,640 - $6,725
125 Added 2.2%
5,801 $277,000
Q4 2018

Jan 22, 2019

SELL
$48.76 - $63.23 $53,002 - $68,731
-1,087 Reduced 16.07%
5,676 $295,000
Q3 2018

Oct 25, 2018

BUY
$55.19 - $62.25 $2,759 - $3,112
50 Added 0.74%
6,763 $420,000
Q2 2018

Jul 27, 2018

BUY
$50.53 - $62.98 $7,579 - $9,447
150 Added 2.29%
6,713 $371,000
Q1 2018

Apr 11, 2018

BUY
$59.92 - $68.98 $6,890 - $7,932
115 Added 1.78%
6,563 $415,000
Q4 2017

Jan 11, 2018

SELL
$59.94 - $65.35 $14,385 - $15,683
-240 Reduced 3.59%
6,448 $395,000
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $369,378 - $426,293
6,688
6,688 $426,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Investors Asset Management Of Georgia Inc Portfolio

Follow Investors Asset Management Of Georgia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Asset Management Of Georgia Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investors Asset Management Of Georgia Inc with notifications on news.